Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enzolytics Inc
(OP:
ENZC
)
0.0029
+0.0001 (+3.57%)
Streaming Delayed Price
Updated: 3:17 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enzolytics Inc
< Previous
1
2
3
Next >
Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.
June 29, 2023
Via
ACCESSWIRE
Enzolytics Offers Update on Virogentics, Inc ITV-1 African Project
June 26, 2023
Via
ACCESSWIRE
Stock Market Surges “Milestones Reached”: SWISF / SKUR.C, NWBO, ENZC, ABML
June 12, 2023
Via
AB Newswire
Enzolytics Offers Update on Virogentics and Sale Transaction, Clinical Trials Progress on European Medicine Agency (EMA) Permitting and Arican ITV-1 Project
June 05, 2023
Via
ACCESSWIRE
Virogentics and Enzolytics Refute Misleading Information Being Circulated on Social Media and Other Internet Outlets Biogenesis to be Featured in June Issue of Life Science Review
May 19, 2023
Via
ACCESSWIRE
Virogentics Inc. Receives Report from Bulgarian Academy of Sciences Administration of ITV-1 to Begin First Week in June 2023
May 16, 2023
Via
ACCESSWIRE
Enzolytics Announces Progress in the Development and Patenting of Feline Leukemia Monoclonal Antibodies
April 04, 2023
Via
ACCESSWIRE
Enzolytics, Inc. Highlights Plans for Promotion of IPF Immune(TM), Its Patented Nutraceutical Supplement
February 28, 2023
Via
ACCESSWIRE
Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:ENZC) 300% Run: RMED, SPPI, HALB, VXRT
May 12, 2023
Via
AB Newswire
Virogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria and Expansion of Nutraceutical Line
May 08, 2023
Via
ACCESSWIRE
Enzolytics Inc. Continues Progress with Business Combination; Biogenysis Announces Team and Plans for Success
April 27, 2023
Via
ACCESSWIRE
Enzolytics, Inc. Finalizing Regulatory Labeling Requirements for Delivery of ITV-1 Treatments for Use in Hospitals in Central and Eastern Africa - Company also Provides Additional Details on the Sale of Biogenysis and Virogentics
April 21, 2023
Via
ACCESSWIRE
Enzolytics, Inc. Announces Execution of Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp. and Updates the Progress on the African Project
April 17, 2023
Via
ACCESSWIRE
Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africa
February 08, 2023
Via
ACCESSWIRE
Enzolytics to Develop Feline Monoclonal Antibodies
January 03, 2023
Via
ACCESSWIRE
Enzolytics, Inc. Announces the Completion of the 2020 and 2021 Audited Financials
December 19, 2022
Via
ACCESSWIRE
Enzolytics, Inc. Announces U.S. Distribution of IPF Immune(TM) and Progress in each of its Therapeutic Platforms
December 13, 2022
Via
ACCESSWIRE
Enzolytics Recognizes World AIDS Day and Highlights the Company's Focus on Producing Effective Therapies for Treating HIV
December 01, 2022
Via
ACCESSWIRE
Enzolytics, Inc. Announces Expansion of Production of Its Monoclonal Antibody Therapeutics and Marketing of IPF Immune(TM)
November 16, 2022
Via
ACCESSWIRE
Enzolytics, Inc. Announces New Advisory Board Member
October 24, 2022
Via
ACCESSWIRE
Enzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study
October 05, 2022
Via
ACCESSWIRE
Enzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodies
September 16, 2022
Via
ACCESSWIRE
Enzolytics Inc. Announces Litigation Success, Accounting Progress and Removal of "Yield" Sign on OTC Markets Stock Quotes
September 14, 2022
Via
ACCESSWIRE
Enzolytics Announces the International Patent Office Search Report finding Novelty and Inventiveness in the Company's Pending International Patent Application Covering its anti-HIV Monoclonal Antibodies.
July 28, 2022
COLLEGE STATION, TX / ACCESSWIRE / July 28, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) ("ENZC" or the "Company"). In the first Official Action on the Company's International Patent Application covering...
From
Enzolytics, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Enzolytics Announces the International Patent Office Search Report finding Novelty and Inventiveness in the Company's Pending International Patent Application Covering its anti-HIV Monoclonal Antibodies.
July 28, 2022
Via
ACCESSWIRE
Enzolytics Announces the Discovery of Conserved Target Sites on the Monkeypox Virus
June 21, 2022
COLLEGE STATION, TX / ACCESSWIRE / June 21, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (ENZC" or the "Company") today announced it has identified conserved, immutable sites (epitopes) on the Monkeypox...
From
Enzolytics, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Enzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcast
May 16, 2022
Phoenix, Arizona--(Newsfile Corp. - May 16, 2022) - The Stock Day Podcast welcomed Enzolytics, Inc. (ENZC) ("the Company"), a drug...
Via
Newsfile
Exposures
COVID-19
CORRECTION: Enzolytics, Inc. Reports Progress and Future Plans
April 25, 2022
This version includes the Safe Harbor statement that was missing from the previous version of this release. COLLEGE STATION, TX / ACCESSWIRE / April 25, 2022 / Enzolytics, Inc. (OTC PINK:ENZC)...
From
Enzolytics, Inc.
Via
AccessWire
Enzolytics, Inc. Reports Progress and Future Plans
April 25, 2022
COLLEGE STATION, TX / ACCESSWIRE / April 25, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Enzolytics continues to make significant progress in its multiple therapeutic platforms...
From
Enzolytics, Inc.
Via
AccessWire
Enzolytics IPF Immune(TM) Introduced to Large and Small Retail Buyers at Recent ECRM "Weight Management, Nutrition, and Vitamin Program"
April 11, 2022
COLLEGE STATION, TX / ACCESSWIRE / April 11, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Large and small retail buyers were introduced to Enzolytics IPF Immune™, an immune...
From
Enzolytics, Inc.
Via
AccessWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.